Viewing Study NCT07365358


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-30 @ 3:15 AM
Study NCT ID: NCT07365358
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-26
First Post: 2026-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
Sponsor: Chong Kun Dang Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module